Actemra

Active Ingredient(s): Tocilizumab
FDA Approved: * January 8, 2010
Pharm Company: * GENENTECH
Category: Arthritis

Tocilizumab, sold under the brand name Actemra among others, is an immunosuppressive drug, used for the treatment of rheumatoid arthritis and systemic juvenile idiopathic arthritis, a severe form of arthritis in children. It is a humanized monoclonal antibody against the interleukin-6 receptor (IL-6R). Interleukin 6 (IL-6) is a cytokine that plays an important role in immune response and is implicated in the pathogenesis of many diseases, such as autoimmune diseases, multiple myeloma and pros... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Actemra 20 mg/ml Intravenous Injection, Solution, Concentrate
NDC: 50242-135
Labeler:
Genentech, Inc.
Actemra 20 mg/ml Intravenous Injection, Solution, Concentrate
NDC: 50242-136
Labeler:
Genentech, Inc.
Actemra 20 mg/ml Intravenous Injection, Solution, Concentrate
NDC: 50242-137
Labeler:
Genentech, Inc.
Actemra 180 mg/ml Subcutaneous Injection, Solution
NDC: 50242-138
Labeler:
Genentech, Inc.

Popular Topics

Swollen and tender legs from Actemra?

My wife has been on Actemra for about 6-7months now and her doctor says it's working, my wife disagrees. Due to her ...

5 REPLIES